KNW insider filing: Robert G. Kidd reports 357.8M shares via Goldeneye 1995 LLC

Rhea-AI Filing Summary

Know Labs filed a Form 3 reporting that Robert Gregory Kidd disclosed beneficial ownership of 357,815,000 common shares held indirectly through Goldeneye 1995 LLC. The shares were issued in a private placement on 08/06/2025 at a purchase price of $0.335 per share. Kidd is identified as a Director, an Officer (CEO, President, Chairman) and a 10% owner, and he is the sole owner and manager of Goldeneye with voting control and investment discretion over the shares.

Positive

• Clear disclosure of beneficial ownership via Form 3 for regulatory transparency
• Size of position disclosed: 357,815,000 common shares held indirectly through Goldeneye 1995 LLC
• Transaction detail provided: Private placement on 08/06/2025 at $0.335 per share

Negative

• None.

Insights

Securities Analyst

TL;DR: Form 3 discloses a large indirect stake of 357.8M shares purchased at $0.335 on 08/06/2025.

The filing documents an initial insider disclosure under Section 16 showing that Goldeneye 1995 LLC received 357,815,000 common shares in a private placement at $0.335 per share. Robert Gregory Kidd is disclosed as the sole owner and manager of Goldeneye and is therefore the beneficial owner with voting control and investment discretion. This is a standard Section 16 disclosure of insider ownership rather than a derivative or option event.

Corporate Governance Expert

TL;DR: Senior officer and director reports sizeable indirect ownership via an entity they control.

The Form 3 confirms that the reporting person holds the disclosed shares indirectly through an entity he solely owns and manages, and that he holds multiple leadership roles with the issuer. The filing provides required transparency about beneficial ownership and control, identifying voting and investment discretion held by the reporting person over the issued shares.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kidd Robert Gregory

(Last) (First) (Middle)

619 WESTERN AVENUE, SUITE 610

(Street)

SEATTLE WA 98104

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2025

3. Issuer Name and Ticker or Trading Symbol
KNOW LABS, INC. [ KNW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, President, Chairman

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	357,815,000(1)	I	By Goldeneye 1995 LLC(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 6, 2025, the Issuer and Goldeneye 1995 LLC ("Goldeneye") closed on a private placement pursuant to which the Issuer issued 357,815,000 shares of common stock to Goldeneye at a per share purchase price of $0.335.

2. The Reporting Person is the sole owner and manager of Goldeneye. The Reporting Person has voting control and investment discretion over the securities held by Goldeneye. As such, the Reporting Person may be deemed to be the beneficial owner of the securities held by Goldeneye.

	/s/ Robert Gregory Kidd	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Know Labs (KNW) disclose in the Form 3 filed by Robert Gregory Kidd?

The Form 3 discloses that Robert Gregory Kidd beneficially owns 357,815,000 common shares held indirectly through Goldeneye 1995 LLC, acquired in a private placement at $0.335 per share on 08/06/2025.

How is Robert Gregory Kidd related to Know Labs (KNW)?

The filing lists Kidd as a Director, an Officer with titles CEO, President, Chairman, and a 10% owner of the issuer.

Who holds voting control over the disclosed shares?

The Form 3 states that Kidd is the sole owner and manager of Goldeneye 1995 LLC and has voting control and investment discretion over the securities held by Goldeneye.

When and how were the 357,815,000 shares issued to Goldeneye?

The shares were issued in a private placement on 08/06/2025 at a per share purchase price of $0.335.

Does the Form 3 report any derivative securities for Robert Gregory Kidd?

No. Table II for derivative securities is empty in the filing; only non-derivative common stock is reported.